YC-backed NxtCure Tests Cancer Drugs on Digital Twins

Y Combinator-backed NxtCure Labs launched as an AI CRO that builds digital twins of cancer patients to test drug efficacy before clinical use, claiming 28% better performance than leading frontier models.

2026-11-12 ~ 2026-11-12 · 2 related posts

• Y Combinator-backed NxtCure Labs launches AI CRO with cancer digital twins — ycombinator · 2026-11-12
• YC-Backed NxtCure Launches AI CRO Testing Cancer Drugs on Human Digital Twins — ycombinator · 2026-11-12